Balyasny Asset Management’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-296,643
| Closed | -$3.08M | – | 3458 |
|
|
2022
Q2 | $3.08M | Buy |
+296,643
| New | +$2.21M | 0.01% | 1165 |
|
|
2019
Q2 | – | Sell |
-70,467
| Closed | -$1.41M | – | 1809 |
|
|
2019
Q1 | $1.41M | Buy |
70,467
+20,710
| +42% | +$378K | 0.01% | 921 |
|
|
2018
Q4 | $820K | Buy |
49,757
+9,071
| +22% | +$153K | 0.01% | 959 |
|
|
2018
Q3 | $724K | Buy |
40,686
+24,483
| +151% | +$554K | ﹤0.01% | 1273 |
|
|
2018
Q2 | $478K | Buy |
+16,203
| New | +$512K | ﹤0.01% | 1368 |
|
|
2017
Q4 | – | Sell |
-400,821
| Closed | -$15.5M | – | 2412 |
|
|
2017
Q3 | $15.5M | Buy |
400,821
+327,447
| +446% | +$12.9M | 0.06% | 386 |
|
|
2017
Q2 | $3.32M | Buy |
+73,374
| New | +$2.8M | 0.01% | 842 |
|
|
2017
Q1 | – | Sell |
-88,891
| Closed | -$3.38M | – | 1844 |
|
|
2016
Q4 | $3.38M | Buy |
+88,891
| New | +$4.23M | 0.02% | 789 |
|
|
2016
Q3 | – | Sell |
-79,345
| Closed | -$2.92M | – | 1347 |
|
|
2016
Q2 | $2.92M | Buy |
79,345
+26,845
| +51% | +$948K | 0.02% | 616 |
|
|
2016
Q1 | $1.65M | Hold |
52,500
| – | – | 0.01% | 721 |
|
|
2015
Q4 | $3.23M | Sell |
52,500
-95,680
| -65% | -$6.04M | 0.02% | 582 |
|
|
2015
Q3 | $10.3M | Buy |
148,180
+141,640
| +2,166% | +$9.84M | 0.08% | 333 |
|
|
2015
Q2 | $443K | Buy |
+6,540
| New | +$305K | ﹤0.01% | 879 |
|
Other funds holding RDUS
Balyasny Asset Management's RDUS Position: Q3 2022 in Review
Balyasny Asset Management sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 296,643 shares — an estimated $3.08M sold.
Balyasny Asset Management first reported a position in RDUS in Q2 2015 and held it in 13 quarters. The position peaked at $15.5M in Q3 2017. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Balyasny Asset Management reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Balyasny Asset Management sold 296,643 Radius Health, Inc. shares in Q3 2022, an estimated $3.08M.
- Balyasny Asset Management first reported a position in Radius Health, Inc. in Q2 2015 and held it in 13 quarters.
- Balyasny Asset Management's Radius Health, Inc. position peaked at $15.5M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.